GE Marquette 12SL ECG Analysis Program: Validation and Accuracy

Document Overview

This document details the validation and accuracy of GE Healthcare's Marquette 12SL ECG Analysis Program. It presents findings from independent assessments reported in scientific literature, covering accuracy levels and the program's overall clinical impact.

Program History and Development

First introduced in 1980, the Marquette 12SL ECG Analysis Program has undergone systematic development and validation. The document outlines its evolution, including integration into computerized electrocardiographs and validation across various platforms like bedside monitors and Holter recorders.

Key Focus Areas

The program's performance is examined through several key areas:

• Measurement Accuracy: Evaluation of how accurately the program measures ECG parameters.
• Interpretation Accuracy: Assessment of the program's ability to provide reliable interpretive statements.
• Overall Impact: Discussion on how computerized ECG analysis, like the 12SL program, assists physicians and improves diagnostic accuracy and efficiency.

The document emphasizes that while computer-assisted interpretation is beneficial, it serves as a tool to support, not replace, physician expertise.